Abstract
Enteroviruses of the human Picornaviridae are common agents of viral myocarditis. Various members of the enterovirus group, e.g. coxsackieviruses and echoviruses, have been associated with viral heart disease. Human enterovirus myocarditis is most often caused by group B coxsackieviruses (CVB) [1–3]. The genetic material of CVB is encoded in a single-stranded RNA molecule of positive polarity and about 7500 nucleotides in length [4, 5]. During replication, the genomic viral plus-strand RNA serves as a template for transcription of minus-strand RNA, an intermediate in the life cycle of enteroviruses, which is transcribed again into large amounts of infectious plus-strand RNA [6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kandolf R (1988) The impact of recombinant DNA technology on the study of enterovirus heart disease. In: Bendinell M, Friedman H (eds) Coxsackieviruses — A general update. Plenum, New York, pp 293–318
McManus BM, Kandolf R (1991) Evolving concepts of cause, consequence, and control in myocarditis. Curr Opin Cardiol 6: 418–427
Martino T, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74: 182–188
Klump WM, Bergmann I, Müller C, Ameis D, Kandolf R (1990) Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5 uridine residues are regained during RNA synthesis. J Virol 64: 1573–1583
Kandolf R, Hofschneider PH (1985) Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 82: 4818–4822
Rückert RR (1990) Picornaviridae and their replication. In: Fields BN, Knipe DM (eds) Virology. Raven, New York, p 507
Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84: 6272–6276
Kandolf R, Kirschner P, Ameis D, Canu A, Erdmann E, Schultheiss HP, Kemkes B, Hofschneider PH (1988) Enteroviral heart disease: Diagnosis by in situ hybridization. In: Schultheiss HP (ed) New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 337–348
Tracy SM, Chapman NM, McManus BM, Pallansch MA, Beck MA, Carstens J (1990) A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22: 403–414
Foulis AK, Farquharson MA, Cameron SO, McGill M, Schönke H, Kandolf R (1990) A search for the presence of the enteroviral capsid protein VP1 in pancreas of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33: 290–298
Kandolf R, Hofschneider PH (1989) Viral heart disease. Springer Semin Immunopathol 11: 1–13
Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89: 314–318
Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82: 8–16
Kandolf R, Klingel K, Zell R, Seiinka H-C, Raab U, Schneider-Brachert W, Bültmann B (1993) Molecular pathogenesis of enterovirus-induced myocarditis: Virus persistence and chronic inflammation. Intervirology 35: 140–151
Kämmerer U, Kunkel B, Korn K (1994) Nested PCR for specific detection and rapid identification of human picornaviruses. J Clin Microbiol 32: 285–291
Huber SA, Job LP, Auld KR, Woodruff JF (1981) Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during coxsackievirus B3 infection. J Immunol 126: 1336–1340
McManus BM, Gauntt CJ, Cassling RS (1987) Immunopathologic basis of myocardial injury. Cardiovasc Clin 18: 163–184
Tracy S, Chapman NM, Beck MA (1991) Molecular biology and pathogenesis of coxsackie B viruses. Rev Med Virol 1: 145–154
Gauntt C, Higdon A, Bowers D, Maull E, Wood J, Crawley R (1993) What lessons can be learned from animal model studies in viral heart disease? Scand J Infect Dis Suppl 88: 49–65
Hohenadl C, Klingel K, Mertsching J, Hofschneider PH, Kandolf R (1991) Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes 5: 1120
Werner S, Klump WM, Schönke H, Hofschneider PH, Kandolf R (1988) Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA 7: 307–316
Matteuci D, Paglianti M, Giangregorio M, Capobianchi MR, Dianzani F, Bendinelli M (1985) Group B coxsackieviruses readily establish persistent infection in human lymphoid cell lines. J Virol 56: 651–654
Oldstone MBA (1989) Viral persistence. Cell 56: 517–520
Pomeroy C, Hilleren PJ, Jordan MC (1991) Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 65: 3330–3334
Klingel K, McManus BM, Kandolf R (1995) Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: A role in pathogenesis? Eur Heart J 16 (Suppl O): 42–45
Mapoles JE, Krah DL, Crowell RL, Philipson L (1985) Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol 55: 560–566
Shafren D, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD (1995) Coxsackievirus B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69: 3873–3877
Lonberg-Holm K, Crowell RL, Philipson L (1976) Unrelated animal viruses share receptors. Nature 259: 679–681
Selinka H-C, Raab de Verdugo U, Homann H, Zell R, Klingel K, Hofschneider PH, Kandolf R (1993) Molekulare Charakterisierung viraler Rezeptoren: Nachweis Coxsackievirus B3-bindender Proteine. Verh Dtsch Ges Path 77: 431
Raab de Verdugo U, Selinka H-C, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R (1995) Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 69: 6751–6757
Crowell RL, Philipson L (1971) Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virol 8: 509–515
Schneider-Schaulies J, Schneider-Schaulies R, Brinkmann R, Tas P, Haibrügge M, Walter U, Holmes HC, TerMeulen V (1992) HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology 191: 765–772
Kandolf R, Canu A, Hofschneider PH (1985) Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol 17: 167–181
Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, Kandolf R (1992) Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J Infect Dis 166: 958–965
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Selinka, HC., Klingel, K., Huber, M., Kramer, B., Kämmerer, U., Kandolf, R. (1997). Molecular Pathogenesis of Myocarditis and Cardiomyopathy: Analysis of Virus-Receptor Interactions and Tyrosine Phosphorylation Events. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-60463-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61358-9
Online ISBN: 978-3-642-60463-8
eBook Packages: Springer Book Archive